Clinical Trials

Neuroscience Institute Will Position Lancaster General Health/Penn Medicine as Area Leader in Neurological Care, Research

Lancaster General Health/Penn Medicine is bringing together a multidisciplinary roster of programs, jointly located at a single, convenient facility, to benefit patients throughout Central Pennsylvania. The Neuroscience Institute, scheduled to open this summer, will facilitate patient access to expert specialty care, provide space for new initiatives and participate in leading-edge clinical investigation.

Moving Oncology Care Forward through Leading-edge Research

WellSpan Health’s nationally recognized oncology clinical research program is at the forefront of emerging cancer therapies, extending additional options and a continued sense of hope to patients for whom standard treatments do not perform as anticipated.

Evaluating the Effectiveness of Epidiolex in Treating Epilepsy

WellSpan Health recently participated in a clinical trial designed to determine the effectiveness of Epidiolex, a purified form of cannabidiol, in epilepsy patients.

Local Access to Leading-edge Research, Treatments

Guided by a team of board-certified physicians, WellSpan Heart & Vascular’s Clinical Trials and Research Program brings to South Central Pennsylvania advanced treatments that patients would otherwise have to travel to receive.